Home » Topics » Regulatory

Regulatory
RSS

FDA approves naloxegol for opioid-induced constipation in patients with chronic pain

Sep. 17, 2014

No Comments

FDA approves Rixubis for children with hemophilia B

Sep. 16, 2014

No Comments

FDA approves Contrave for chronic weight management

Sep. 12, 2014

No Comments

New indication for Spiriva Respimat approved in Europe

Sep. 10, 2014

No Comments

FDA awards pembrolizumab accelerated approval for melanoma

Sep. 5, 2014

No Comments

FDA approves Vimpat as monotherapy for partial-onset seizures

Sep. 1, 2014

No Comments

European Commission approves Bristol-Myers Squibb's Daklinza for HCV

Aug. 28, 2014

No Comments

FDA approves Triumeq for HIV

Aug. 26, 2014

No Comments

Apixaban granted FDA approval for DVT and PE

Aug. 22, 2014

No Comments

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Aug. 21, 2014

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves naloxegol for opioid-induced constipation in patients with chronic pain

FDA approves Rixubis for children with hemophilia B

FDA approves Contrave for chronic weight management

New indication for Spiriva Respimat approved in Europe

FDA awards pembrolizumab accelerated approval for melanoma

FDA approves Vimpat as monotherapy for partial-onset seizures

European Commission approves Bristol-Myers Squibb's Daklinza for HCV

FDA approves Triumeq for HIV

Apixaban granted FDA approval for DVT and PE

Marketing approval granted for KRONUS ZnT8Ab ELISA Assay for diagnosis of type 1 diabetes

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Regulatory RSS

Regulatory
RSS